Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while...
Co-Chair Edward Shahady, MD, FAAFP, ABCL, interviews Kevin Peterson, MD, MPH, on what happens to Beta Cells after 3 years of GLP-1 administration, compared with insulin.
